A Retrospective,Cohort study to evaluate the efficacy and safety of Trabectedin in patients with recurrent soft tissue sarcoma
Latest Information Update: 14 Nov 2016
Price :
$35 *
At a glance
- Drugs Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2016 New trial record